1)Yannuzzi LA, Sorenson J, Spaide RF et al:Idiopathic polypoidal choroidal vasculopathy(PCV). Retina 10:1-8, 1990
2)Maruko I, Iida T, Saito M et al:Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144:15-22, 2007
3)Uyama M, Matsubara T, Fukushima I et al:Idiopathic polypoidal choridal vasculopathy in Japanese patients. Arch Ophthalmol 117:1035-1042, 1999
4)吉村長久:ポリープ状脈絡膜血管症.眼紀 55:155-172,2004
5)佐藤 拓.堀内康史.岸 章治他:ポリープ状脈絡膜血管症の黄斑下血腫に対する硝子体内ガス注入術.眼紀 57:29-33,2006
6)Ohji M, Saito Y, Hayashi A et al:Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 116:1326-1332, 1998
7)Tong JP, Chan WM, Liu DT et al:. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 141:456-462, 2006
8)Gomi F, Sawa M, Sakaguchi H et al:Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol 92:70-73, 2008
9)Kokame GT, Ling Y, Lai JC:Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy:6-months results. Br J Ophthalmol 94:297-301, 2010
10)Hikichi T, Otsuka H, Higuchi M et al:Improvement of angiographic findings of polypoidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months. Am J Ophthalmol 150:674-682, 2010
11)日本ポリープ状脈絡膜血管症研究会:ポリープ状脈絡膜血管症の診断基準.日眼会誌 109:417-427,2005
12)Bennet SR, Folk JC, Blodi CF et al:Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 109:33-37, 1990.